Navigation Links
Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
Date:9/25/2007

matrix for the drug delivery, oncology, and dermatology markets. The company's portfolio of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its first partnership is with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets. In addition, the company has received FDA approval for two products: Cumulase(R) and HYLENEX, for use as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids. HYLENEX is partnered with Baxter Healthcare Corporation. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need.

Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the development of Chemophase and the release of interim data related to current clinical trials) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including regulatory approval requirements and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Halozyme Contact Investor Relations Contact<
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Baebies, Inc. today announced the completion of a ... round of financing included key investors Rex Health Ventures, ... Triad, LLC, the Duke Angel Network and a loan ... Liquid Logic,s (ALL) former investors including Charleston Angel Partners, ... "Rex is pleased to support this promising young company," ...
(Date:7/28/2015)...  Zipnosis, the first virtual care solution to empower health ... own branded virtual care service line, announced an agreement with ... is currently in use. ... As health systems consider ... value of providing their own branded online care for common ...
(Date:7/28/2015)... , July 28, 2015 ANI Pharmaceuticals, ... Company plans to release its second quarter and year-to-date ... the opening of the U.S. financial markets. The earnings ... section of the Company,s website, www.anipharmaceuticals.com . ... Executive Officer, and Charlotte C. Arnold , Vice ...
Breaking Medicine Technology:Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Zipnosis Announces Group Health to use Virtual Care Service Line 2Zipnosis Announces Group Health to use Virtual Care Service Line 3ANI Pharmaceuticals Schedules Conference Call for Second Quarter and Year-to-Date 2015 Financial Results 2
... Mind Technologies, Inc . ( http://mindtechnologiesinc.com ) (Pink Sheets: ... on The Company,s proprietary EEG/ BCI headset, which is ... the world leader in EEG/ BCI technology, Mind Technologies ... process of developing a state-of-the-art headset that would revolutionize ...
... Awarepoint Corporation , the leading ... announced that the U.S. Patent and Trademark Office has ... interaction-based tracking system that helps hospitals enhance their patient ... outcomes. (Logo:   http://photos.prnewswire.com/prnh/20100127/LA44915LOGO ) ...
Cached Medicine Technology:Mind Technologies Inc. Developing Revolutionary EEG Brain Computer Interface 2Awarepoint Awarded U.S. Patent for its Revolutionary Tag-to-Tag Communication Technology 2
(Date:7/28/2015)... , ... July 28, 2015 , ... Please join us for the 5th Annual ... Town Center located at Gary Avenue and Lies Road in Carol Stream. All are welcome. ... raise awareness, and provide education and help to support individuals and families affected by a ...
(Date:7/28/2015)... ... July 28, 2015 , ... One ... including Runner’s World Magazine, is plantar fasciitis . Zensah, the Miami-based compression ... Designed by a professional athletic trainer, the Zensah Ankle Support’s primary benefits include ...
(Date:7/28/2015)... ... July 28, 2015 , ... Intellitec Solutions has been ... annual ranking of Value Added Resellers of ERP Software is a look at the ... with. This honor represents the second such award in 2015 for Intellitec Solutions, following ...
(Date:7/28/2015)... Louis, MO (PRWEB) , ... July 28, 2015 , ... ... back pain comes in as a close second. Clients suffering from headaches and back ... clients get started with chiropractic treatment, The Joint 's nine offices in the ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... the post surgical spine patient with discussion and demonstration of specific rehabilitation exercises ... Gain insight into the actual surgical process with an extensive interview conducted by ...
Breaking Medicine News(10 mins):Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:The Joint St. Louis Offers “2 for Thursday” Special, Chiropractic Care Services, Affordable Back Pain Relief 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6
... COLUMBUS, Ohio, Jan. 19 Abbott ... voluntary recall of,ZonePerfect(R) Chocolate Peanut Butter bars, ZonePerfect(R) ... in response to the widening,recall involving peanut butter ... America (PCA). PCA was one of the ...
... with early-stage lung cancer are not seen when patients ... the January issue of Archives of Surgery , ... more deaths in the United States than any other ... resectionor surgery to remove a portion of the lungprovides ...
... setting, study finds , , MONDAY, Jan. 19 (HealthDay News) ... on the rise among American children, a new report ... the bacteria Staphylococcus aureus -- referred to ... methicillin -- are moving beyond the traditional confines of ...
... /PRNewswire-FirstCall/ - The Board of Directors of NUCRYST ... B. Holtz as interim President and Chief Executive ... Chairman, effective immediately. Mr. Holtz replaces Thomas E. ... Officer. Mr. Carragher, currently lead director of NUCRYST, ...
... Aribex, Inc., a world leader in handheld x-ray ... second U.S. patent for its NOMAD Handheld X-ray System. ... concept of having all components of the x-ray system ... development of the world,s first handheld x-ray system. Aribex ...
... ethnicity, types of seafood consumed , , MONDAY, Jan. 19 (HealthDay ... for a living, and her ethnicity may all be ... new survey says. , The report, published in the January ... in coastal areas in the Northeastern United States had ...
Cached Medicine News:Health News:Abbott Nutrition Announces Voluntary Recall of ZonePerfect(R) Chocolate Peanut Butter Bars, ZonePerfect(R) Peanut Toffee Bars and NutriPals(TM) Peanut Butter Chocolate Bars in U.S., Mexico, New Zealand and Singapore 2Health News:Study examines racial disparities in survival among patients diagnosed with lung cancer 2Health News:MRSA Infections Spreading to Kids in Community 2Health News:MRSA Infections Spreading to Kids in Community 3Health News:NUCRYST appoints interim CEO 2Health News:NUCRYST appoints interim CEO 3Health News:Aribex(R) Awarded Patents for Handheld X-ray 2Health News:Women in Coastal Areas Have Higher Mercury Levels 2
... Blades are designed for the retraction ... basal lesions. Reduced obstruction when working ... instrument, range of blade sizes from ... Quick change and release, malleable material ...
Permanently sharp, slightly angulated blade, delicate sharp dissection, excellent balanced, ergonomic design....
Epstein Curettes 3.0 mm, length 8" (203 mm)....
Codman-Cone Ring Curettes, ring diameter (I.D.) 5 / 16" (8 mm), total length 9" (229 mm)....
Medicine Products: